ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)

CUSIP: 77313F106

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / Common Stock
Shares outstanding
109,265,652
Total 13F shares
53,342,815
Share change
+407,350
Total reported value
$1,116,479,207
Put/Call ratio
0%
Price per share
$20.93
Number of holders
113
Value change
+$14,452,216
Number of buys
70
Number of sells
36

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 77313F106?
CUSIP 77313F106 identifies RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RTW INVESTMENTS, LP
13F
Company
15%
16,812,491
$234,534,000 31 Mar 2020
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
2.7%
2,965,485
$41,369,000 31 Mar 2020
13F
BlackRock Finance, Inc.
13F
Company
2.5%
2,705,952
$37,748,000 31 Mar 2020
13F
PERCEPTIVE ADVISORS LLC
13F
Company
2%
2,189,010
$30,537,000 31 Mar 2020
13F
VANGUARD GROUP INC
13F
Company
1.7%
1,857,107
$25,907,000 31 Mar 2020
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
1.5%
1,681,434
$23,456,000 31 Mar 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1.5%
1,679,480
$23,428,000 31 Mar 2020
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
1.5%
1,677,367
$23,399,000 31 Mar 2020
13F
Cormorant Asset Management, LP
13F
Company
1.4%
1,568,550
$21,881,000 31 Mar 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.4%
1,527,758
$21,312,000 31 Mar 2020
13F
LORD, ABBETT & CO. LLC
13F
Company
1.4%
1,513,354
$21,111,000 31 Mar 2020
13F
Boxer Capital, LLC
13F
Company
1.3%
1,466,051
$20,451,000 31 Mar 2020
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
1.3%
1,415,000
$19,739,000 31 Mar 2020
13F
FMR LLC
13F
Company
1.1%
1,149,587
$16,037,000 31 Mar 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.98%
1,065,969
$14,870,000 31 Mar 2020
13F
STATE STREET CORP
13F
Company
0.88%
965,715
$13,472,000 31 Mar 2020
13F
Vivo Capital, LLC
13F
Company
0.79%
860,648
$12,006,000 31 Mar 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.71%
776,517
$10,832,000 31 Mar 2020
13F
MORGAN STANLEY
13F
Company
0.7%
760,443
$10,608,000 31 Mar 2020
13F
Ghost Tree Capital, LLC
13F
Company
0.59%
650,000
$9,068,000 31 Mar 2020
13F
Invesco Ltd.
13F
Company
0.53%
581,278
$8,109,000 31 Mar 2020
13F
DEUTSCHE BANK AG\
13F
Company
0.48%
524,184
$7,312,000 31 Mar 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.48%
519,456
$7,246,000 31 Mar 2020
13F
NORTHERN TRUST CORP
13F
Company
0.38%
411,081
$5,735,000 31 Mar 2020
13F
HealthCor Management, L.P.
13F
Company
0.34%
369,639
$5,156,000 31 Mar 2020
13F
FRANKLIN RESOURCES INC
13F
Company
0.33%
364,100
$5,079,000 31 Mar 2020
13F
PUTNAM INVESTMENTS LLC
13F
Company
0.31%
343,000
$4,785,000 31 Mar 2020
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.31%
335,016
$4,673,000 31 Mar 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.27%
298,777
$4,168,000 31 Mar 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.26%
287,222
$4,007,000 31 Mar 2020
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.25%
275,486
$3,843,000 31 Mar 2020
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.25%
275,300
$3,840,000 31 Mar 2020
13F
BARCLAYS PLC
13F
Company
0.23%
247,755
$3,456,000 31 Mar 2020
13F
FRAZIER MANAGEMENT LLC
13F
Company
0.19%
210,000
$2,930,000 31 Mar 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.19%
208,552
$2,910,000 31 Mar 2020
13F
Tekla Capital Management LLC
13F
Company
0.19%
207,555
$2,895,000 31 Mar 2020
13F
D. E. Shaw & Co., Inc.
13F
Company
0.19%
207,403
$2,893,000 31 Mar 2020
13F
AXA S.A.
13F
Company
0.19%
203,431
$2,838,000 31 Mar 2020
13F
FEDERATED HERMES, INC.
13F
Company
0.16%
170,545
$2,379,000 31 Mar 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.15%
165,015
$2,302,000 31 Mar 2020
13F
Samsara BioCapital, LLC
13F
Company
0.12%
128,197
$1,788,000 31 Mar 2020
13F
Bank of New York Mellon Corp
13F
Company
0.11%
122,979
$1,716,000 31 Mar 2020
13F
ALPS ADVISORS INC
13F
Company
0.09%
98,491
$1,374,000 31 Mar 2020
13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
13F
Company
0.09%
97,800
$1,364,000 31 Mar 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.09%
93,600
$1,306,000 31 Mar 2020
13F
SYNOVUS FINANCIAL CORP
13F
Company
0.07%
77,178
$1,076,000 31 Mar 2020
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.06%
67,990
$948,000 31 Mar 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.06%
67,742
$945,000 31 Mar 2020
13F
Swiss National Bank
13F
Company
0.06%
63,500
$886,000 31 Mar 2020
13F
Allianz Asset Management GmbH
13F
Company
0.06%
63,250
$882,000 31 Mar 2020
13F

Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q2 2020

As of 30 Jun 2020, ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by 113 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,342,815 shares. The largest 10 holders included RTW INVESTMENTS, LP, BlackRock Inc., TANG CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, EVENTIDE ASSET MANAGEMENT, LLC, and Cormorant Asset Management, LP. This page lists 113 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
102
Q2 2020 holders
113
Holder diff
11
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.